Sergio Garbarino
Paola Lanteri2
Nicola L. Bragazzi
Egeria Scoditti- 1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal/Child Sciences, Polyclinic Hospital San Martino Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Genova, Genova, Italy
- 2Department of Diagnostics and Applied Technology, Neurophysiopathology Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Neurologico Carlo Besta, Milan, Italy
- 3Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada
- 4National Research Council, Institute of Clinical Physiology, Lecce, Italy
Immunosenescence and Elderly Frailty
The ongoing pandemic of COVID-19, caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), has dramatically shown how the elderly are fragile in spite of advancement in healthcare and medical attention in Western countries (1). With the global growth of the elderly population, the burden of noncommunicable diseases, including heart disease, cancers, metabolic, neurologic and autoimmune diseases, as well as infectious diseases is projected to dramatically increase, thus imposing critical public health challenges and demanding multidisciplinary efforts to develop more effective preventive and therapeutic strategies. Lying along the causal path between aging and negative health outcomes, a progressive functional decline of the innate and adaptive immunity (immunosenescence) occurs with age, which leads to increased risk for infectious diseases and ineffective response to vaccination, as well as for other non-infectious immune-related chronic degenerative diseases (2).
The unsuccessful immune response to SARS-CoV-2 has been associated with a dysfunctional innate immune response, while neutralizing antibody response by adaptive immunity correlates with beneficial outcomes (3). Aging is accompanied by a decline in the production of naïve T cells and naive B cells, as a consequence of reduced thymic output, bone marrow and lymph nodes function (4). Decreased proliferation and differentiation of activated T and B cells also occur in lymph nodes with aging. Consequently, these age-related changes in the number and function of effector cells impair the immune responses to emerging infection, predisposing older adults to a higher risk of viral and bacterial infections (5).
It has been increasingly shown that this immune dysfunction and associated frailty are, to a relevant extent, accounted for by gender- and age-related changes in the circadian system (6).
The Circadian System
Biological life is regulated by, and depends on, circadian clocks that allow homeostatic daily rhythms in behavior, physiology, endocrinology and metabolism, with the sleep-wake cycles alternation as the most directly experienced expression of this regulatory system.
The circadian system regulates daily rhythms in sleep-wake, hunger-satiety, and body temperature. Circadian clocks include the central pacemaker situated in the suprachiasmatic nucleus in the brain, and peripheral clocks in various tissues (7). By receiving light inputs via the retina, the suprachiasmatic nucleus is entrained to the 24-h day/night cycle, and in turn synchronizes peripheral clocks. At the cellular level, molecular clock components generate circadian fluctuation in basic cellular functions, e.g., gene expression, protein translation, and intracellular signaling, which are all involved in fundamental processes including cell cycle regulation, nutrient sensing/utilization, metabolism, stress response, redox regulation, detoxification, and cell defense (immunity and inflammation) in a tissue-specific manner (8).
Gender and Age-Related Changes in Sleep
The cyclic occurrence of periods of non-rapid-eye-movement (NREM) sleep and rapid-eye-movement (REM) sleep characterizes the organization of human sleep. Current evidence confirms the presence of age-related changes in sleep duration and architecture, so that older adults could have a reduced ability to sleep rather than a reduced sleep need (9). Decreases in slow-wave sleep (SWS), slow waves (SW; <4 Hz and >75 μV) and slow-wave activity (SWA; spectral power 0.5–4 Hz) represent one of the main age-related changes in sleep. A factor modifying the impact of aging on sleep is gender. Indeed, women present sharper and steeper SW compared with men. The production of flatter slopes of SW rather than sudden SW slope (200 μV/s) is more frequently observed in older man compared with older women (10). During young adulthood, women reach both puberty and their peak eveningness more precociously compared with men. Sleep is longer in duration in women than in men until age 50–60, that coincides with menopause. Core body temperature and melatonin rhythms are phase advanced, and the intrinsic circadian period is shorter in women compared with men (9). Sleep-endocrine activities also exhibit gender differences and changes in nocturnal hormone secretion occur during aging. The sleep-related secretion of different hormones (particularly neuropeptides and steroids) shows distinct patterns, exerting specific effects on sleep (11): studies in male and female rats found modifications in responses of anterior pituitary to CRH, LHRH, TRH, and GHRH throughout the whole life span (12). Some hormones (GHRH, ghrelin, galanin, NPY) positively regulate sleep, at least in males: GHRH promotes NREM sleep, and stimulates GH. Other peptides (CRH, somatostatin) impair selective NREM sleep: CRH contributes to wakefulness and to the HPA hormones. Notably, in women GHRH induces CRH-like effects. Cortisol secretion is higher in normal young females than in males, and contributes to REM sleep maintenance. Aging as well as some pathological conditions such as depression are accompanied by modifications in the CRH:GHRH ratio with an increase of CRH. In females the menopause is the crucial point for the occurrence of impaired sleep, while in men the sleep quality gets worse steadily: different concurrent decreases of SWS, SWA and GH secretion emerge already during the third decade of life (11). These sleep age-related changes in sleep-endocrine activities, albeit different in both male and females, can impair health and increase the risk for several diseases and infections in elderly populations (13).
Inflammation, Sickness, and Sleep
Inflammation is a physiological response of the immune system to infection and injury regulated by different immune cells and inflammatory factors. Inflammatory molecules (cytokines, prostaglandins, and complement factors) act locally but also at a distance. Locally, they take action on nearby immune cells to stimulate their recruitment/activation, and on the vascular system to induce vasodilation and vascular permeability. They also communicate over great distances to other organs, establishing a systemic inflammation that can involve brain inflammation, also known as neuroinflammation (14). During infections and injuries, peripheral cytokines can come into contact with the brain via the humoral routes and the neural routes, working in parallel and synergistically to cause neuroinflammation. A strategy to adaptively recover from infections and injuries includes sickness, which induces an inflammatory response associated with physiological and behavioral changes involving disturbed sleep. Evidence point to a reciprocal interactions between sleep and immune function (13), where poor sleep alters immune function and immune activation alters sleep. Inflammatory mechanisms, involving the pro-inflammatory cytokines interleukin (IL) 1α, IL1β, IL6, interferon (IFN)α, IFNγ, tumor necrosis factor (TNF)-α, and TNF-β, are induced by pathogen and are able to modulate sleep organization and main sleep-wake behavior (15). Although IL-1 is commonly associated with pathological states and plays critical roles in host defense, this cytokine is also implicated in the regulation of physiological sleep (15, 16).
Immunosenescence, Sleep, and Frailty
With aging, the circadian indicators of the sleep-wake organization, i.e., sleep onset, body core temperature, motor activity, and melatonin phase, have an earlier daytime emergence (6); the circadian phase advances in parallel and the rhythms amplitude is reduced while the period is shortened. Evidence from animal studies indicate that the activity of the suprachiasmatic nuclei orchestrating the circadian rhythms is decreased with aging and the clock gene expression is impaired (17, 18); the autonomic nervous system cyclic organization also changes with age (6). In peripheral blood cells, level of Bmal1 expression, a core clock gene and a regulator of innate immunity, was shown to correlate inversely with age in women (19). Animal results further support these age-associated changes in clock gene expression, but also suggest a causal role for these changes in the aging process. For example, knockouts of the clock genes Bmal1 and Period result in an accelerated aging in Drosophila and mice, characterized by increased tissue decline, cognitive dysfunction, and shorter lifespan compared with age-matched wild-type controls (6). On the other hand, the increased susceptibility to respiratory viral diseases in winter may be associated with the seasonal variation of Bmal1 expression, whose low levels in winter correlate with enhanced viral disease (20).
One of the most consistent evidence of age-associated circadian disruption is the age-associated changes in sleep, with its quantity progressively reducing (sleep deprivation) and quality worsening from around 55 yrs. of age to become worst over 65 yrs. also in subjects without major sleep disorders. Major sleep disorders and especially sleep deprivation are associated to immune dysfunction and chronic inflammation and to higher risks of infection and psychiatric, cerebral/cardiovascular, metabolic/hormonal co-morbidity and related mortality irrespective of age, according to surveys and population-based studies (21, 22). Congruently, the disruption of circadian rhythms results in comparable outcomes and in the elderly adds and contribute to the cumulative decline in several (brain, endocrine, immune, muscle) physiological systems during a lifetime.
The circadian system and sleep have emerged as important intertwined regulators of immune defense (23, 24). Trafficking of immune cells and proinflammatory cytokines are under circadian regulation and oscillate in accordance with the rest/activity cycle (5, 25). Animal studies found that global, brain or peripheral knockout of clock genes alters this circadian fluctuation and leads to exacerbated inflammatory response to infection or other pathogenic stimuli, oxidative stress, and age-related phenotypes, thus revealing a direct role for clock genes in suppressing chronic inflammation and ensuring its timely resolution (26, 27).
Additionally, adequate sleep quantity and quality support the immune function, reduce infectious risks and improve vaccination responses by regulating immunological memory and humoral immunity (24). On the contrary, sleep deprivation is associated with chronic inflammation, greater susceptibility to infection and worse clinical protection after vaccines (24), as well as with increased risk for inflammatory diseases and total mortality (22). Notably, both sleep-wake cycle and circadian clock components contribute to maintain blood-brain barrier function, important for the neuroimmune system (28). Furthermore, the circadian rhythmicity of gene expression related to immune function and stress response, among others, is disrupted after sleep deprivation, as experimentally demonstrated in humans (29), underscoring the interrelationship between sleep and circadian system and their interface with health. Together, observational and experimental data point to immune dysfunction and chronic, low-grade activation of inflammation in connecting circadian disruption to negative health consequences in aging (Figure 1).
Figure 1. Schematic organization of the bidirectional relationship between central and peripheral clock genes expression and their effects on circadian rhythms, i.e., sleep-wake cycle, and on immunity. Infectious agent can interfere with both the expression of clock genes and the activation of the immune system. Host susceptibility to an invading pathogen modify during 24 h and with aging.
The spatiotemporal regulation of gene expression and associated functions contribute to maintain physiology and behavior.
Future Directions: Therapeutic Opportunities Thinking About Age-Related Sleep Changes
From accumulating evidence new therapeutic opportunities have been generated for two main reasons: first, by leveraging rhythmic aspects of some diseases in occurrence, including cardiovascular or neurological ones (30) and infection disease also knowing that the timing of virus infection during the day influences infection disease outcome and this effect is found under different types of light–dark cycles (12-h light/12-h darkness compared with 24-h darkness), and in genetic models of circadian disruption (31); second, by optimizing timing of drug administration in order to increase its efficacy and minimize adverse side effects (chronopharmacology) (32). Murine and human studies have suggested that the efficacy of vaccination is under circadian control. Animal studies show that the immune response to vaccination is improved when vaccination is performed at the time of higher circadian expression of TLR9 (Toll-like receptor 9) (33). Likewise, a time dependance of the antibody response to viral challenge in humans was also shown: morning vaccination against hepatitis A and influenza virus increased the antibody response as compared to afternoon vaccination (34). The majority of drugs approved by the FDA have targets showing circadian rhythm in expression and functions (8), and the drug absorption, transportation, conversion and cell uptake also show rhythmic expression. As a consequence, any strategies to improve drug efficacy in the elderly should consider the impact of circadian rhythmicity on treatment efficacy. Chronopharmacology can therefore constitute an additional factor of variability in drug response in the elderly.
Conclusions
The relationship between aging and circadian disruption is bidirectional, with aging associated with circadian dysfunction, and behavior and genetic disruption of the circadian clock leading to aging-like phenotypes. The result is the establishing of circular, self-sustaining mechanisms of dysregulation with potentially severe impact on health. The bidirectional relationship among sleep/circadian rhythm and immunity has received minor attention to date mainly if we consider the emergence of sleep disorders in the adulthood that persist until the elderly. It remains unclear the extent to which sleep disorders affect the immunosenescence in the later life. During the lifetime, a progressive cumulative decline in physiological homeostasis occurs, thus reducing the quality of life, and promoting isolation and adverse health outcome in the elderly (35). In this subpopulation with combined motility and cognition impairment, multimorbidity, sarcopenia and reduced autonomy (~7–12% in Western countries), the misalignment between the circadian sleep-wake cycle and the daily activities further reduces adaptation and can result in highest incidence of severe adverse medical or traumatic events (36). By decreasing the amplitude in the rhythms of locomotor activity and temperature, circadian rhythmicity could worsen motility, as recently demonstrated in a mouse model of Bmal1 knockout (26).
The link among the disorders of circadian clock, sleep and immunosenescence qualify today as a high-priority healthcare, welfare and social constraints with high estimated direct and indirect costs, that hover higher in the elderly (36) if counterbalancing behaviors or measures are not devised and widely represented in the medical practice. The field of circadian rhythm has recently become a potential therapeutic target for the treatment of diseases as we learned by infectious models, thus improving life expectancy and quality of life of older persons.
The circadian pattern of the immune system contributes to shape the host ability to respond to viral infections and the host–pathogen interaction. Viral infections and other infectious diseases influence the host circadian clock drive. Therefore, in the complex host–pathogen interaction a role of timing can be suggested, offering new therapeutic opportunities based on chrono-modulated antiviral strategies. A more in-depth research in the interrelationship of circadian system and immunity in the elderly, with multidisciplinary competences, from (chrono)biology, (chrono)pharmacology, neuroimmunology, sleep to integrative physiology, is advisable and possibly overdue.
Author Contributions
SG and WS conceived the manuscript. SG, EG, and PL wrote the manuscript. NB and WS revised the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Koff WC, Williams MA. Covid-19 and immunity in aging populations - a new research agenda. N Engl J Med. (2020) 383:804–5. doi: 10.1056/NEJMp2006761
2. Fung CH, Vitiello MV, Alessi CA, Kuchel GA, AGS/NIA Sleep Conference Planning Committee and Faculty. Report and Research Agenda of the American Geriatrics Society and National Institute on Aging Bedside-to-Bench Conference on sleep, circadian rhythms, and aging: new avenues for improving brain health, physical health, and functioning. J Am Geriatr Soc. (2016) 64:e238–47. doi: 10.1111/jgs.14493
3. Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. (2020) 42:505–14. doi: 10.1007/s11357-020-00193-1
4. Thompson HL, Smithey MJ, Surh CD, Nikolich-Zugich J. Functional and homeostatic impact of age-related changes in lymph node stroma. Front Immunol. (2017) 8:706. doi: 10.3389/fimmu.2017.00706
5. Smithey MJ, Renkema KR, Rudd BD, Nikolich-Zugich J. Increased apoptosis, curtailed expansion and incomplete differentiation of CD8(+) T-cells combine to decrease clearance of L. monocytogenes in old mice. Eur J Immunol. (2011) 41:1352–64. doi: 10.1002/eji.201041141
6. Hood S, Amir S. The aging clock: circadian rhythms and later life. J Clin Invest. (2017) 127:437–46. doi: 10.1172/JCI90328
7. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. (2012) 35:445–62. doi: 10.1146/annurev-neuro-060909-153128
8. Mure LS, Le HD, Benegiamo G, Chang MW, Rios L, Jillani N, et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science. (2018) 359:eaao0318. doi: 10.1126/science.aao0318
9. Jonasdottir SS, Minor K, Lehmann S. Gender differences in nighttime sleep patterns and variability across the adult lifespan: a global-scale wearables study. Sleep. (2020) 4:zsaa169. doi: 10.1093/sleep/zsaa169
10. Rosinvil T, Bouvier J, Dubé J, Lafrenière A, Bouchard M, Cronier J, et al. Are age and sex effects on sleep slow waves only a matter of EEG amplitude? Sleep. (2020) 15:zsaa186. doi: 10.1093/sleep/zsaa186
11. Steiger A. Neurochemical regulation of sleep. J Psychiatr Res. (2007) 41:537–52. doi: 10.1016/j.jpsychires.2006.04.007
12. Senovilla L, García-Sancho J, Villalobos C. Changes in expression of hypothalamic releasing hormone receptors in individual rat anterior pituitary cells during maturation, puberty and senescence. Endocrinology. (2005) 146:4627–34. doi: 10.1210/en.2005-0836
13. Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nat Rev Neurosci. (2009) 10:199–210. doi: 10.1038/nrn2576
14. Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci Biobehav Rev. (2015) 57:30–45. doi: 10.1016/j.neubiorev.2015.07.015
15. Ashley M, Ingiosi AM, Raymond RM Jr, Pavlova MN, Opp MR. Selective contributions of neuronal and astroglial interleukin-1 receptor 1 to the regulation of sleep. Brain Behav Immun. (2015) 48:244–57. doi: 10.1016/j.bbi.2015.03.014
16. Ames C, Boland E, Szentirmai É. Effects of macrophage depletion on sleep in mice. PLoS ONE. (2016) 11:e0159812. doi: 10.1371/journal.pone.0159812
17. Garbarino S, Lanteri P, Prada V, Falkenstein M, Sannita WG. Circadian rhythms, sleep, and aging. J Psychophysiol. (2020) 34:1–9. doi: 10.1027/0269-8803/a000267
18. Chen CY, Logan RW, Ma T, Lewis DA, Tseng GC, Sibille E, et al. Effects of aging on circadian patterns of gene expression in the human prefrontal cortex. Proc Natl Acad Sci USA. (2016) 113:206–11. doi: 10.1073/pnas.1508249112
19. Ando H, Ushijima K, Kumazaki M, Takamura T, Yokota N, Saito T, et al. Influence of age on clock gene expression in peripheral blood cells of healthy women. J Gerontol A Biol Sci Med Sci. (2010) 65:9–13. doi: 10.1093/gerona/glp160
20. Dopico XC, Evangelou M, Ferreira RC, Guo H, Pekalski ML, Smyth DJ, et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat Commun. (2015) 6:7000. doi: 10.1038/ncomms8000
21. Potter GD, Skene DJ, Arendt J, Cade JE, Grant PJ, Hardie LJ. Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures. Endocr Rev. (2016) 37:584–608. doi: 10.1210/er.2016-1083
22. Hall MH, Smagula SF, Boudreau RM, Ayonayon HN, Goldman SE, Harris TB, et al. Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the Health, Aging and Body Composition Study. Sleep. (2015) 38:189–95. doi: 10.5665/sleep.4394
23. Lananna BV, Musiek ES. The wrinkling of time: aging, inflammation, oxidative stress, and the circadian clock in neurodegeneration. Neurobiol Dis. (2020) 139:104832. doi: 10.1016/j.nbd.2020.104832
24. Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev. (2019) 99:1325–80. doi: 10.1152/physrev.00010.2018
25. Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. (2013) 13:190–8. doi: 10.1038/nri3386
26. Nguyen KD, Fentress SJ, Qiu Y, Yun K, Cox JS, Chawla A. Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. Science. (2013) 341:1483–8. doi: 10.1126/science.1240636
27. Man K, Loudon A, Chawla A. Immunity around the clock. Science. (2016) 354:999–1003. doi: 10.1126/science.aah4966
28. Cuddapah VA, Zhang SL, Sehgal A. Regulation of the blood-brain barrier by circadian rhythms and sleep. Trends Neurosci. (2019) 42:500–10. doi: 10.1016/j.tins.2019.05.001
29. Möller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA. (2013) 110:E1132–41. doi: 10.1073/pnas.1217154110
30. Thosar SS, Butler MP, Shea SA. Role of the circadian system in cardiovascular disease. J Clin Invest. (2018) 128:2157–67. doi: 10.1172/JCI80590
31. Sengupta S, Tang SY, Devine JC, Anderson ST, Nayak S, Zhang SL, et al. Circadian control of lung inflammation in influenza infection. Nat Commun. (2019) 10:4107. doi: 10.1038/s41467-019-11400-9
32. Dallmann R, Okyar A, Lévi F. Dosing-time makes the poison: circadian regulation and pharmacotherapy. Trends Mol Med. (2016) 22:430–45. doi: 10.1016/j.molmed.2016.03.004
33. Silver AC, Arjona A, Walker WE, Fikrig E. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity. (2012) 36:251–61. doi: 10.1016/j.immuni.2011.12.017
34. Kirby T. Influenza vaccination in the morning improves response. Lancet Respir Med. (2016) 4:435. doi: 10.1016/S2213-2600(16)30100-X
35. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. (2013) 381:752–62. doi: 10.1016/S0140-6736(12)62167-9
Keywords: aging, circadian rhythm, clock gene, chronotherapy, healthcare, infection, immunity, sleep
Citation: Garbarino S, Lanteri P, Sannita WG, Bragazzi NL and Scoditti E (2020) Circadian Rhythms, Sleep, Immunity, and Fragility in the Elderly: The Model of the Susceptibility to Infections. Front. Neurol. 11:558417. doi: 10.3389/fneur.2020.558417
Received: 28 July 2020; Accepted: 02 December 2020;
Published: 18 December 2020.
Edited by:
Ahmed S. BaHammam, King Saud University, Saudi ArabiaReviewed by:
Axel Steiger, Ludwig Maximilian University of Munich, GermanyCopyright © 2020 Garbarino, Lanteri, Sannita, Bragazzi and Scoditti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sergio Garbarino, sgarbarino.neuro@gmail.com